Recurrent testis cancer: Seeding from retroperitoneal nodes after complete remissions by chemotherapy

M. Kamer, R. G. Rowland, Lawrence Einhorn, J. P. Donohue

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Routine retroperitoneal lymph node dissection is generally not required after a complete remission is achieved by chemotherapy in initially disseminated nonseminomatous testis cancer. However, in patients with multiple relapses retroperitoneal lymph node dissection should be considered even if the retroperitoneum is unremarkable by radiographic staging. We report on a patient with initial stage III disease in whom a complete clinical response to chemotherapy was achieved multiple times but there was repeatedly re-seeding of the lungs from an undetected focus of nodal cancer later proved by retroperitoneal lymph node dissection. Controversies in management as well as potential mechanisms of drug resistance are discussed.

Original languageEnglish
Pages (from-to)1196-1198
Number of pages3
JournalJournal of Urology
Volume130
Issue number6
StatePublished - 1983

Fingerprint

Testicular Neoplasms
Lymph Node Excision
Drug Therapy
Drug Resistance
Recurrence
Lung
Neoplasms

ASJC Scopus subject areas

  • Urology

Cite this

Recurrent testis cancer : Seeding from retroperitoneal nodes after complete remissions by chemotherapy. / Kamer, M.; Rowland, R. G.; Einhorn, Lawrence; Donohue, J. P.

In: Journal of Urology, Vol. 130, No. 6, 1983, p. 1196-1198.

Research output: Contribution to journalArticle

@article{cc7bdcc682664da3ba36b10211367f2d,
title = "Recurrent testis cancer: Seeding from retroperitoneal nodes after complete remissions by chemotherapy",
abstract = "Routine retroperitoneal lymph node dissection is generally not required after a complete remission is achieved by chemotherapy in initially disseminated nonseminomatous testis cancer. However, in patients with multiple relapses retroperitoneal lymph node dissection should be considered even if the retroperitoneum is unremarkable by radiographic staging. We report on a patient with initial stage III disease in whom a complete clinical response to chemotherapy was achieved multiple times but there was repeatedly re-seeding of the lungs from an undetected focus of nodal cancer later proved by retroperitoneal lymph node dissection. Controversies in management as well as potential mechanisms of drug resistance are discussed.",
author = "M. Kamer and Rowland, {R. G.} and Lawrence Einhorn and Donohue, {J. P.}",
year = "1983",
language = "English",
volume = "130",
pages = "1196--1198",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Recurrent testis cancer

T2 - Seeding from retroperitoneal nodes after complete remissions by chemotherapy

AU - Kamer, M.

AU - Rowland, R. G.

AU - Einhorn, Lawrence

AU - Donohue, J. P.

PY - 1983

Y1 - 1983

N2 - Routine retroperitoneal lymph node dissection is generally not required after a complete remission is achieved by chemotherapy in initially disseminated nonseminomatous testis cancer. However, in patients with multiple relapses retroperitoneal lymph node dissection should be considered even if the retroperitoneum is unremarkable by radiographic staging. We report on a patient with initial stage III disease in whom a complete clinical response to chemotherapy was achieved multiple times but there was repeatedly re-seeding of the lungs from an undetected focus of nodal cancer later proved by retroperitoneal lymph node dissection. Controversies in management as well as potential mechanisms of drug resistance are discussed.

AB - Routine retroperitoneal lymph node dissection is generally not required after a complete remission is achieved by chemotherapy in initially disseminated nonseminomatous testis cancer. However, in patients with multiple relapses retroperitoneal lymph node dissection should be considered even if the retroperitoneum is unremarkable by radiographic staging. We report on a patient with initial stage III disease in whom a complete clinical response to chemotherapy was achieved multiple times but there was repeatedly re-seeding of the lungs from an undetected focus of nodal cancer later proved by retroperitoneal lymph node dissection. Controversies in management as well as potential mechanisms of drug resistance are discussed.

UR - http://www.scopus.com/inward/record.url?scp=0021024020&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021024020&partnerID=8YFLogxK

M3 - Article

C2 - 6196491

AN - SCOPUS:0021024020

VL - 130

SP - 1196

EP - 1198

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 6

ER -